These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12067545)

  • 61. Rapid methods for screening low molecular mass compounds non-covalently bound to proteins using size exclusion and mass spectrometry applied to inhibitors of human cytomegalovirus protease.
    Siegel MM; Tabei K; Bebernitz GA; Baum EZ
    J Mass Spectrom; 1998 Mar; 33(3):264-73. PubMed ID: 9538525
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
    Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
    Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of a novel series of inhibitors of human cytomegalovirus primase.
    Cushing TD; Adrian J; Chen X; DiMaio H; Doughan B; Flygare J; Liang L; Mayorga V; Miao S; Mellon H; Peterson MG; Powers JP; Spector F; Stein C; Wright M; Xu D; Ye Q; Jaen J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4879-83. PubMed ID: 16814545
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors.
    Zhuang W; Zhao X; Zhao G; Guo L; Lian Y; Zhou J; Fang D
    Bioorg Med Chem; 2009 Sep; 17(18):6540-6. PubMed ID: 19703775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-arylproline analogs.
    Bilodeau F; Bailey MD; Bhardwaj PK; Bordeleau J; Forgione P; Garneau M; Ghiro E; Gorys V; Halmos T; Jolicoeur ES; Leblanc M; Lemke CT; Naud J; O'Meara J; White PW; Llinàs-Brunet M
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4267-71. PubMed ID: 23735741
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of herpes proteases and antiviral activity of 2-substituted thieno[2,3-d]oxazinones.
    Jarvest RL; Pinto IL; Ashman SM; Dabrowski CE; Fernandez AV; Jennings LJ; Lavery P; Tew DG
    Bioorg Med Chem Lett; 1999 Feb; 9(3):443-8. PubMed ID: 10091699
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease.
    Bowsher M; Hiebert S; Li R; Wang AX; Friborg J; Yu F; Hernandez D; Wang YK; Klei H; Rajamani R; Mosure K; Knipe JO; Meanwell NA; McPhee F; Scola PM
    Bioorg Med Chem Lett; 2018 Jan; 28(1):43-48. PubMed ID: 29162454
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
    Sun J; Mei H
    Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
    [TBL] [Abstract][Full Text] [Related]  

  • 69. trans-3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: prime site exploration using an oxygen linker.
    Sellner H; Cottens S; Cumin F; Ehrhardt C; Kosaka T; Lorthiois E; Ostermann N; Webb RL; Rigel DF; Wagner T; Maibaum J
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1787-1791. PubMed ID: 25754490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease.
    Jiang Y; Andrews SW; Condroski KR; Buckman B; Serebryany V; Wenglowsky S; Kennedy AL; Madduru MR; Wang B; Lyon M; Doherty GA; Woodard BT; Lemieux C; Geck Do M; Zhang H; Ballard J; Vigers G; Brandhuber BJ; Stengel P; Josey JA; Beigelman L; Blatt L; Seiwert SD
    J Med Chem; 2014 Mar; 57(5):1753-69. PubMed ID: 23672640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of fused bicyclic derivatives of pyrrolidine and imidazolidinone as dengue virus-2 NS2B-NS3 protease inhibitors.
    Weng Z; Shao X; Graf D; Wang C; Klein CD; Wang J; Zhou GC
    Eur J Med Chem; 2017 Jan; 125():751-759. PubMed ID: 27721158
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and inhibitory activity of acyl-peptidyl-pyrrolidine derivatives toward post-proline cleaving enzyme; a study of subsite specificity.
    Saito M; Hashimoto M; Kawaguchi N; Shibata H; Fukami H; Tanaka T; Higuchi N
    J Enzyme Inhib; 1991; 5(1):51-75. PubMed ID: 1669438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potent ketoamide inhibitors of HCV NS3 protease derived from quaternized P1 groups.
    Venkatraman S; Velazquez F; Wu W; Blackman M; Madison V; Njoroge FG
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2151-5. PubMed ID: 20226659
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NVP-DPP728 (1-[[[2-[(5-cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)- pyrrolidine), a slow-binding inhibitor of dipeptidyl peptidase IV.
    Hughes TE; Mone MD; Russell ME; Weldon SC; Villhauer EB
    Biochemistry; 1999 Sep; 38(36):11597-603. PubMed ID: 10512614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound.
    Kazmierski WM; Maynard A; Duan M; Baskaran S; Botyanszki J; Crosby R; Dickerson S; Tallant M; Grimes R; Hamatake R; Leivers M; Roberts CD; Walker J
    J Med Chem; 2014 Mar; 57(5):2058-73. PubMed ID: 24568313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
    Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
    J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Peptide inhibitors of hepatitis C virus NS3 protease.
    Portal-Núñez S; González-Navarro CJ; García-Delgado M; Vizmanos JL; Lasarte JJ; Borrás-Cuesta F
    Antivir Chem Chemother; 2003 Sep; 14(5):225-33. PubMed ID: 14694985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
    Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
    Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.